Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0fd6fdb8cc439061143dc8a966303868 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2533-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2503-02 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0695 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5011 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
filingDate |
2015-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79a11388eb592c1cf6002941d631a170 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d5b4c0586b3a3555a98108a0a7bffeb6 |
publicationDate |
2016-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20160125741-A |
titleOfInvention |
Cancer stem cell expressing SOX-2 and a method for manufacturing thereof |
abstract |
The present invention relates to a cancer stem cell expressing SOX-2 and a method for producing the same. Since the cancer stem cells of the present invention have characteristics of pure cancer stem cells, they are expected to contribute greatly to the characterization of tumors using cancer stem cells and the development of therapeutic agents. |
priorityDate |
2015-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |